Participation of kinins in the inhibitory action of captopril on acute hypertension induced by L-NAME in anesthetized rats

被引:0
作者
deMoura, R
Leao, MC
机构
关键词
L-NAME; captopril; HOE; 140; rat arterial blood pressure;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of the present study was to investigate the role of bradykinin in the inhibitory action of captopril in hypertension induced by L-NAME in anesthetized rats. Male Wistar rats (260-320 g) were anesthetized with chloralose and arterial blood pressure was recorded with a polygraph pressure transducer. The hypertensive effect of L-NAME was studied in rats pretreated with saline, captopril or HOE 140 plus captopril. The effect of captopril was also studied during the sustained presser effect of L-NAME. The acute presser effect of L-NAME (10 mg/kg, iv) was significantly reduced by iv pretreatment with 2 mg/kg captopril (Delta increase of 49 +/- 4.9 mmHg reduced to 20 +/- 5.4 mmHg, P = 0.01), The presser effect of L-NAME (Delta increase of 38 +/- 4.8 mmHg) observed in rats pretreated with captopril and HOE 140 (0.1 mg/kg, iv) was not significantly different from that induced by L-NAME in rats pretreated with saline (P = 0.09). During the sustained presser effect induced by L-NAME (Delta increase of 49 +/- 4.9 mmHg) captopril induced a significant (P<0.05) reduction in arterial blood pressure (Delta decrease of 22 +/- 3.0 mmHg). The present results demonstrate that the acute presser effect of L-NAME is reduced by captopril and this inhibitory effect may be partly dependent on the potentiation of the vasodilator actions of bradykinin.
引用
收藏
页码:1219 / 1223
页数:5
相关论文
共 20 条
[1]   ENDOTHELIUM-DEPENDENT RELAXATIONS ARE AUGMENTED IN RATS CHRONICALLY TREATED WITH THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL [J].
BOSSALLER, C ;
AUCHSCHWELK, W ;
WEBER, F ;
GOTZE, S ;
GRAFE, M ;
GRAF, K ;
FLECK, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S91-S95
[2]   EFFECTS OF BRADYKININ B-2 RECEPTOR ANTAGONISM ON THE HYPOTENSIVE EFFECTS OF ACE-INHIBITION [J].
BOUAZIZ, H ;
JOULIN, Y ;
SAFAR, M ;
BENETOS, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (03) :717-722
[3]  
CONRAD KP, 1992, AM J PHYSIOL, V262, pR1137, DOI 10.1152/ajpregu.1992.262.6.R1137
[4]   EVIDENCE THAT THE AUTONOMIC NERVOUS-SYSTEM PLAYS A MAJOR ROLE IN THE L-NAME INDUCED HYPERTENSION IN CONSCIOUS RATS [J].
CUNHA, RS ;
CABRAL, AM ;
VASQUEZ, EC .
AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (09) :806-809
[5]  
DEMOURA RS, 1992, BRIT J PHARMACOL, V107, pP199
[6]   CONTROL OF REGIONAL BLOOD-FLOW BY ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
GARDINER, SM ;
COMPTON, AM ;
BENNETT, T ;
PALMER, RMJ ;
MONCADA, S .
HYPERTENSION, 1990, 15 (05) :486-492
[7]  
GOLDSCHMIDT JE, 1991, J PHARMACOL EXP THER, V257, P1136
[8]   MECHANISMS INVOLVED IN THE CARDIOVASCULAR-RENAL ACTIONS OF NITRIC-OXIDE INHIBITION [J].
MANNING, RD ;
HU, LF ;
WILLIAMSON, TD .
HYPERTENSION, 1994, 23 (06) :951-956
[9]   ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR(S) AND THE POTENTIATION OF KININS BY CONVERTING-ENZYME INHIBITORS [J].
MOMBOULI, JV ;
VANHOUTTE, PM .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (05) :S19-S27
[10]   ENDOGENOUS VASOACTIVE SYSTEMS AND THE PRESSER EFFECT OF ACUTE N-OMEGA-NITRO-L-ARGININE METHYL-ESTER ADMINISTRATION [J].
NAFRIALDI, N ;
JOVER, B ;
MIMRAN, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (05) :765-771